152 related articles for article (PubMed ID: 17999185)
1. Serum prolidase and IGF-1 as non-invasive markers of hepatic fibrosis during four different periods after bile-duct ligation in rats.
Tarçin O; Gedik N; Karakoyun B; Tahan V; Sood G; Celikel C; Tözün N
Dig Dis Sci; 2008 Jul; 53(7):1938-45. PubMed ID: 17999185
[TBL] [Abstract][Full Text] [Related]
2. In vivo inefficiency of pentoxifylline and interferon-alpha on hepatic fibrosis in biliary-obstructed rats: assessment by tissue collagen content and prolidase activity.
Tarçin O; Avşar K; Demirtürk L; Gültepe M; Oktar BK; Ozdoğan OC; Tarçin O; Baloğlu H; Gürbüz AK
J Gastroenterol Hepatol; 2003 Apr; 18(4):437-44. PubMed ID: 12653893
[TBL] [Abstract][Full Text] [Related]
3. The Effects of Hyperbaric Oxygen Treatment on Total Antioxidant Capacity and Prolidase Activity after Bile Duct Ligation in Rats.
Terzioglu D; Uslu L; Simsek G; Atukeren P; Erman H; Gelisgen R; Ayvaz S; Aksu B; Uzun H
J Invest Surg; 2017 Dec; 30(6):376-382. PubMed ID: 27922759
[TBL] [Abstract][Full Text] [Related]
4. Time course of collagen peak in bile duct-ligated rats.
Tarcin O; Basaranoglu M; Tahan V; Tahan G; Sücüllü I; Yilmaz N; Sood G; Snyder N; Hilman G; Celikel C; Tözün N
BMC Gastroenterol; 2011 Apr; 11():45. PubMed ID: 21527001
[TBL] [Abstract][Full Text] [Related]
5. Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model.
Liu JY; Ding ZY; Zhou ZY; Dai SZ; Zhang J; Li H; Du Q; Cai YY; Shang QL; Luo YH; Xiao EH
World J Gastroenterol; 2021 Dec; 27(47):8156-8165. PubMed ID: 35068860
[TBL] [Abstract][Full Text] [Related]
6. The effects of pegylated interferon alpha 2b on bile-duct ligation induced liver fibrosis in rats.
Canbakan B; Akin H; Tahan G; Tarcin O; Eren F; Atug O; Tahan V; Imeryuz N; Yapicier O; Avsar E; Tozun N
Ann Hepatol; 2009; 8(3):234-40. PubMed ID: 19841503
[TBL] [Abstract][Full Text] [Related]
7. Effects of nebivolol on liver fibrosis induced by bile duct ligation in Wistar rats.
Teixeira C; Franco E; Oliveira PA; Colaço B; Gama A; Carrola J; Pires CA; Colaço A; Pires MJ
In Vivo; 2013; 27(5):635-40. PubMed ID: 23988899
[TBL] [Abstract][Full Text] [Related]
8. HIF-1 α as a Key Factor in Bile Duct Ligation-Induced Liver Fibrosis in Rats.
Moczydlowska J; Miltyk W; Hermanowicz A; Lebensztejn DM; Palka JA; Debek W
J Invest Surg; 2017 Feb; 30(1):41-46. PubMed ID: 27260943
[TBL] [Abstract][Full Text] [Related]
9. Antioxidants vitamin E and C attenuate hepatic fibrosis in biliary-obstructed rats.
Soylu AR; Aydogdu N; Basaran UN; Altaner S; Tarcin O; Gedik N; Umit H; Tezel A; Dokmeci G; Baloglu H; Ture M; Kutlu K; Kaymak K
World J Gastroenterol; 2006 Nov; 12(42):6835-41. PubMed ID: 17106933
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of malnutrition, bile duct ligation and galactosamine injection in young rats on serum levels and gene expression of IGF-binding proteins.
Holt RI; Baker AJ; Jones JS; Crossey PA; Stone NM; Preedy VR; Miell JP
J Endocrinol; 1996 Jun; 149(3):465-72. PubMed ID: 8691105
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of gastrodin on bile duct ligation-induced hepatic fibrosis in rats.
Zhao S; Li N; Zhen Y; Ge M; Li Y; Yu B; He H; Shao RG
Food Chem Toxicol; 2015 Dec; 86():202-7. PubMed ID: 26498411
[TBL] [Abstract][Full Text] [Related]
12. Curcumin attenuates hepatic fibrosis and insulin resistance induced by bile duct ligation in rats.
Eshaghian A; Khodarahmi A; Safari F; Binesh F; Moradi A
Br J Nutr; 2018 Aug; 120(4):393-403. PubMed ID: 29880071
[TBL] [Abstract][Full Text] [Related]
13. Effects of a long-acting somatostatin analogue, lanreotide, on bile duct ligation-induced liver fibrosis in rats.
Tahan G; Eren F; Tarçin O; Akin H; Tahan V; Şahın H; Özdoğan O; İmeryüz N; Çelıkel Ç; Avşar E; Tözün N
Turk J Gastroenterol; 2010 Sep; 21(3):287-92. PubMed ID: 20931434
[TBL] [Abstract][Full Text] [Related]
14. The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats.
Tahan G; Tarcin O; Tahan V; Eren F; Gedik N; Sahan E; Biberoglu N; Guzel S; Bozbas A; Tozun N; Yucel O
Dig Dis Sci; 2007 Dec; 52(12):3348-54. PubMed ID: 17436097
[TBL] [Abstract][Full Text] [Related]
15. Herbal compound 861 prevents hepatic fibrosis by inhibiting the TGF-β1/Smad/SnoN pathway in bile duct-ligated rats.
Chi C; Liu XY; Hou F; Yu XZ; Li CY; Cui LJ; Liu RX; Yin CH
BMC Complement Altern Med; 2018 Feb; 18(1):52. PubMed ID: 29402324
[TBL] [Abstract][Full Text] [Related]
16. Protective effect of bicyclol against bile duct ligation-induced hepatic fibrosis in rats.
Zhen YZ; Li NR; He HW; Zhao SS; Zhang GL; Hao XF; Shao RG
World J Gastroenterol; 2015 Jun; 21(23):7155-64. PubMed ID: 26109801
[TBL] [Abstract][Full Text] [Related]
17. Silymarin-loaded Eudragit(®) RS100 nanoparticles improved the ability of silymarin to resolve hepatic fibrosis in bile duct ligated rats.
Younis N; Shaheen MA; Abdallah MH
Biomed Pharmacother; 2016 Jul; 81():93-103. PubMed ID: 27261582
[TBL] [Abstract][Full Text] [Related]
18. Chronic bile duct obstruction induces changes in plasma and hepatic levels of cytokines and nitric oxide in the rat.
Fernández-Martínez E; Pérez-Alvarez V; Tsutsumi V; Shibayama M; Muriel P
Exp Toxicol Pathol; 2006 Aug; 58(1):49-58. PubMed ID: 16617007
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor I-dependent regulation of prolidase activity in cultured human skin fibroblasts.
Miltyk W; Karna E; Wołczyński S; Pałka J
Mol Cell Biochem; 1998 Dec; 189(1-2):177-83. PubMed ID: 9879669
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib-loaded PAMAM dendrimer attenuates liver fibrosis and its complications in bile-duct-ligated rats.
Shafie F; Nabavizadeh F; Shafie Ardestani M; Panahi M; Adeli S; Samandari H; Ashabi G
Can J Physiol Pharmacol; 2019 Aug; 97(8):691-698. PubMed ID: 31071278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
